Non-invasive biomarkers in lung cancer.
1/5 보강
Lung cancer is the leading cause of cancer-related deaths worldwide, with its high mortality rate largely due to challenges in early detection.
APA
Baskar R, Saravanan S, et al. (2026). Non-invasive biomarkers in lung cancer.. Clinica chimica acta; international journal of clinical chemistry, 578, 120552. https://doi.org/10.1016/j.cca.2025.120552
MLA
Baskar R, et al.. "Non-invasive biomarkers in lung cancer.." Clinica chimica acta; international journal of clinical chemistry, vol. 578, 2026, pp. 120552.
PMID
40816620 ↗
Abstract 한글 요약
Lung cancer is the leading cause of cancer-related deaths worldwide, with its high mortality rate largely due to challenges in early detection. Blood- and tissue-based biomarkers are widely used for diagnosis; however, they often cause patient discomfort, require complex analytical methods, and rely heavily on expert interpretation for disease staging. Non-blood-based biomarkers from sputum, urine, saliva, sweat, and exhaled breath are emerging as effective alternatives for lung cancer diagnostics. These methods are non-invasive, cost-effective, and allow safer, repeated sampling, making them suitable for prognostic use. Urine contains biomarkers such as volatile organic compounds (VOCs) and circulating tumour DNA, providing valuable metabolic insights. Saliva offers proteins, microRNAs, and exosomal biomarkers that reflect systemic disease-related changes. Sputum contains diverse molecular markers that aid early detection. Exhaled breath carries microRNAs and VOCs, representing another promising diagnostic route. Overall, non-invasive biomarker platforms significantly reduce procedural risks and enable earlier lung cancer detection. Their advancement holds substantial potential to improve patient outcomes globally.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.
- Association of patient health education with the postoperative health related quality of life in low- intermediate recurrence risk differentiated thyroid cancer patients.